A pilot study for novel infection prevention mask during esophagogastroduodenoscopy
Not Applicable
- Conditions
- pper gastrointestinal diseases
- Registration Number
- JPRN-UMIN000040815
- Lead Sponsor
- ational Cancer Center Hospital
- Brief Summary
The median number of microparticles in volunteers 1, 2, and 3 with and without the aerosol-exposure protection (AP) mask was 8.5 and 110.0, 7.0 and 51.5, and 8.0 and 95.0, respectively (p<0.01). Using the AP mask, microparticles were reduced by approximately 92%. The median distances of microparticle scattering without the AP mask were 60, 0, and 68 in volunteers 1, 2, and 3, respectively. In the 30 patients, the mean SpO2 was 96.3%, and adverse events, such as aspiration pneumonia, were not observed.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 33
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients with positive PCR test for SARS-CoV-2 2) Patients with suspected SARS-CoV-2 infection 3) The physicians determine that participation in this study is not appropriate.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The prevention of aerosol exposure The range of contamination of sheets outside the infection prevention mask.
- Secondary Outcome Measures
Name Time Method